BioPharma Dive
- Company typePrivate
- Founded-
- HeadquartersWashington, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
BioPharma Dive firmographics
Firmographics- Name
- BioPharma Dive
- Legal name
- TechTarget, Inc.
- Website
- https://biopharmadive.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
BioPharma Dive industry classification
Industry- Product category
- Pharmaceutical & Biotech Industry News (B2B Trade Media)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where BioPharma Dive is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Markets served
BioPharma Dive business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Sponsored Content and Advertising: BioPharma Dive generates revenue through sponsored content, branded webinars, podcasts, and display advertising from pharmaceutical companies, biotech firms, and life sciences service providers.
- Webinars and Virtual Events: The platform hosts sponsored webinars and virtual events for life sciences companies looking to reach industry professionals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free newsletter subscriptions covering industry news |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
BioPharma Dive product offering
Product offeringCore offering
BioPharma Dive is a B2B industry news publication that delivers daily and weekly email newsletters, long-form investigative articles, and interactive data trackers covering the biotechnology and pharmaceutical sectors. Core topics include pharma, biotech, FDA decisions, clinical trials, M&A deals, drug pricing, and gene therapy, with supplementary offerings including a content library, industry events listings, and a press release distribution platform for life sciences companies.
Product overview
BioPharma Dive is a B2B news publication delivering daily and weekly newsletters covering the biotech and pharma industry. The core offering consists of four specialized newsletters (Daily Dive, Commercialization Weekly, Gene Therapy Weekly, Emerging Biotech Weekly) and an online news portal organized by topics including Pharma, Biotech, FDA, Clinical Trials, Deals, Drug Pricing, and Gene Therapy. Supporting products include a Library of whitepapers and webinars, data trackers for IPO performance and venture funding, a patent cliff tracker, an events listing platform, and a press release distribution service. Deep Dive provides long-form investigative content. The publication is part of Informa TechTarget's network of industry-focused dive publications.
Differentiator
Problem solved
Functional benefit
Products and services
- Daily Dive Newsletter Daily email newsletter delivering the top biotech and pharma industry news to subscribers Monday through Friday.
- Commercialization Weekly Newsletter Weekly newsletter focused on drug commercialization, salesforces, market competition, drug advertising, and patents.
- Gene Therapy Weekly Newsletter Weekly newsletter covering gene replacement therapy, gene editing, engineered cell therapy, manufacturing, pricing, and reimbursement.
- Emerging Biotech Weekly Newsletter Weekly newsletter covering biotech startup launches, funding, IPOs, industry profiles, and research collaborations.
- BioPharma Dive Library Repository of whitepapers, webinars, podcasts, playbooks, trendlines, surveys, and industry reports covering pharma and biotech topics for industry professionals.
- Biotech IPO Performance Tracker Interactive tracker monitoring biotech IPO performance and market activity for investors and industry professionals.
- Biotech Venture Capital Funding Startup Tracker Tracking tool for biotech startup funding rounds and venture capital investment activity.
- Patent Cliff Tracker Tool tracking drug patent expirations and monopoly expiration dates for major pharmaceuticals.
- Industry Events Listing and promotion platform for pharma and biotech industry events, tradeshows, webinars, and editorial events.
- Press Releases Platform for biotech and pharma companies to submit and distribute press releases to the BioPharma Dive industry audience.
- Deep Dive In-depth industry analysis and feature articles from award-winning journalists on pharma and biotech topics.
Companies that use BioPharma Dive
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
BioPharma Dive technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioPharma Dive partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Almac Clinical ServicesminorSponsored podcast series 'From Protocol to Patient: Inside Clinical Supply' exploring how clinical trial supplies move from early planning to global delivery.
Scale indicators1 record
Recent moves4 records
Expansion highlights4 records
BioPharma Dive competitors and assessment
Company assessmentDirect peers
- Drug Discovery & Development: Trade publication focused on early-stage drug discovery, R&D, and biopharma technology—competes for sponsor relationships with biotech tool vendors and CROs similar to BioPharma Dive's coverage of clinical trial services.
- STAT News: Premium biotech/pharma news outlet covering drug development, FDA, health policy, and clinical trials. Directly competes with BioPharma Dive for executive readership and pharma sponsorship dollars.
- BioCentury: Long-established biotech intelligence service providing news, analysis, and proprietary data products (e.g., BCIQ) to biopharma business development and licensing teams. Competes on the data intelligence layer overlapping with BioPharma Dive's trackers.
- Fierce Biotech / Fierce Pharma: Veteran pharma/biotech trade publication network owned by Questex, with newsletters, special reports, and events covering the same enterprise audience as BioPharma Dive.
- Endpoints News: Direct competitor covering biotech news, R&D, clinical trials, and FDA decisions for pharma professionals. Competes head-to-head for the same enterprise subscriber base and pharma/biotech sponsor budgets.
- MedCity News: Healthcare business news outlet covering biotech, pharma, digital health, and healthcare business. Overlaps with BioPharma Dive's audience of pharma executives and investors.
Broad incumbents
- PharmaVoice: Sister brand within the Informa TechTarget network covering pharma leadership, patient engagement, and industry issues—shares parent infrastructure and overlapping readers.
- Healthcare Dive: Sister publication under Informa TechTarget covering healthcare delivery and policy; serves adjacent rather than overlapping audience of pharma executives, but shares sponsor pool and brand infrastructure.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
BioPharma Dive social profiles
Digital presenceBioPharma Dive financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioPharma Dive leadership team
Management profileNumber of profiles
BioPharma Dive funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioPharma Dive M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioPharma Dive
What does BioPharma Dive do?
BioPharma Dive is a B2B industry news publication that delivers daily and weekly email newsletters, long-form investigative articles, and interactive data trackers covering the biotechnology and pharmaceutical sectors. Core topics include pharma, biotech, FDA decisions, clinical trials, M&A deals, drug pricing, and gene therapy, with supplementary offerings including a content library, industry events listings, and a press release distribution platform for life sciences companies.
Is BioPharma Dive a public or private company?
BioPharma Dive is a private company. It is classified as corporate owned and is currently operating.
When was BioPharma Dive founded?
BioPharma Dive was founded in -1. It employs 51 to 100 people.
Where is BioPharma Dive based?
BioPharma Dive is headquartered in Washington, United States, in the North America region.
How does BioPharma Dive make money?
Two revenue lines are on record. Sponsored Content and Advertising is the primary driver. The others are webinars and Virtual Events.
Who are BioPharma Dive's main competitors?
Direct peers on record are Drug Discovery & Development, STAT News, BioCentury, Fierce Biotech / Fierce Pharma, Endpoints News and MedCity News. Broad incumbents are PharmaVoice and Healthcare Dive.
Does BioPharma Dive have an API?
No public API is recorded for BioPharma Dive.
What industry is BioPharma Dive in?
BioPharma Dive's product category is Pharmaceutical & Biotech Industry News (B2B Trade Media). Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence.